A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth

Cancer Letters

Volumn 319, Issue 2, 2012, Pages 136-143

  Bidwell, Gene L ^a   Perkins, Eddie ^a,b   Raucher, Drazen ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; C Myc; Elastin like polypeptide; Therapeutic peptide; Thermal targeting

Indexed keywords

ELASTIN LIKE POLYPEPTIDE; MYC PROTEIN; MYC PROTEIN INHIBITOR; POLYPEPTIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TARGETING; HYPERTHERMIC THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PEPTIDES; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84859505371     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.042     Document Type: Article

References (30)

1. Bidwell G.L., Raucher D. Therapeutic peptides for cancer therapy. Part I - Peptide inhibitors of signal transduction cascades. Expert Opin. Drug Deliv. 2009, 6:1033-1047.
2. Raucher D., Moktan S., Massodi I., Bidwell G.L. Therapeutic peptides for cancer therapy. Part II - Cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opin. Drug Deliv. 2009, 6:1049-1064.
3. Talmadge J.E. Pharmacodynamic aspects of peptide administration biological response modifiers. Adv. Drug Deliv. Rev. 1998, 33:241-252.
4. Sadler K., Eom K.D., Yang J.L., Dimitrova Y., Tam J.P. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002, 41:14150-14157.
5. Bidwell G.L., Davis A.N., Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J. Contr. Release 2009, 135:2-10.
6. Bidwell G.L., Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol. Cancer Ther. 2005, 4:1076-1085.
7. Urry D.W., Luan C.-H., Parker T.M., Gowda D.C., Prasad K.U., Reid M.C., Safavy A. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J. Am. Chem. Soc. 1991, 113:4346-4348.
8. Liu W., Dreher M.R., Furgeson D.Y., Peixoto K.V., Yuan H., Zalutsky M.R., Chilkoti A. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J. Contr. Release 2006, 116:170-178.
9. Dreher M.R., Liu W., Michelich C.R., Dewhirst M.W., Chilkoti A. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res. 2007, 67:4418-4424.
10. Draeger L.J., Mullen G.P. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR. J. Biol. Chem. 1994, 269:1785-1793.
11. Giorello L., Clerico L., Pescarolo M.P., Vikhanskaya F., Salmona M., Colella G., Bruno S., Mancuso T., Bagnasco L., Russo P., Parodi S. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res. 1998, 58:3654-3659.
12. Meyer D.E., Kong G.A., Dewhirst M.W., Zalutsky M.R., Chilkoti A. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res. 2001, 61:1548-1554.
13. Dunham L.J., Stewart H.L. A survey of transplantable and transmissible animal tumors. J. Natl. Cancer Inst. 1953, 13:1299-1377.
14. Sugiura K., Stock C.C. Studies in a tumor spectrum. I. Comparison of the action of methylbis (2-chloroethyl)amine and 3-bis(2-chloroethyl)aminomethyl-4-methoxymethyl -5-hydroxy-6-methylpyridine on the growth of a variety of mouse and rat tumors. Cancer 1952, 5:382-402.
15. Ewens A., Mihich E., Ehrke M.J. Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. Anticancer Res. 2005, 25:3905-3915.
16. Lefor A.T., Makohon S., Ackerman N.B. The effects of hyperthermia on vascular permeability in experimental liver metastasis. J. Surg. Oncol. 1985, 28:297-300.
17. Fujiwara K., Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol. Jpn. 1990, 40:79-84.
18. Ram Z., Cohen Z.R., Harnof S., Tal S., Faibel M., Nass D., Maier S.E., Hadani M., Mardor Y. Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy. Neurosurgery 2006, 59:949-955.
19. discussion 955-946.
20. ter Haar G.R. High intensity focused ultrasound for the treatment of tumors. Echocardiography 2001, 18:317-322.
21. Clement G.T. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 2004, 42:1087-1093.
22. Burfeindt M.J., Zastrow E., Hagness S.C., Van Veen B.D., Medow J.E. Microwave beamforming for non-invasive patient-specific hyperthermia treatment of pediatric brain cancer. Phys. Med. Biol. 2011, 56:2743-2754.
23. Zastrow E., Hagness S.C., Van Veen B.D., Medow J.E. Time-multiplexed beamforming for noninvasive microwave hyperthermia treatment. IEEE Trans. Biomed. Eng. 2011, 58:1574-1584.
24. Zastrow E., Hagness S.C., Van Veen B.D. 3D computational study of non-invasive patient-specific microwave hyperthermia treatment of breast cancer. Phys. Med. Biol. 2010, 55:3611-3629.
25. Raoof M., Curley S.A. Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma. Int. J. Hepatol. 2011, 2011:676957.
26. Ohguri T., Yahara K., Moon S.D., Yamaguchi S., Imada H., Terashima H., Korogi Y. Deep regional hyperthermia for the whole thoracic region using 8MHz radiofrequency-capacitive heating device. relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int. J. Hyperthermia 2011, 27:20-26.
27. Ohguri T., Imada H., Yahara K., Morioka T., Nakano K., Terashima H., Korogi Y. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:128-135.
28. Gellermann J., Wlodarczyk W., Feussner A., Fahling H., Nadobny J., Hildebrandt B., Felix R., Wust P. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int. J. Hyperthermia 2005, 21:497-513.
29. Massodi I., Raucher D. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells. J. Drug Target 2007, 15:611-622.
30. Maeda H., Seymour L.W., Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug. Chem. 1992, 3:351-362.